Sickle Cell Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for sickle cell disease. 32 active patents protecting 1 drugs from 1+ originators. First major cliff: 2032. Daily refresh.

1
Approved drugs
32
Active US patents
27/100
Avg vulnerability
$250M
Annual revenue covered

Originators in Sickle Cell Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Global Blood Theraps 32 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating sickle cell disease. Each bar = one year. Y-axis scaled to peak year (9 patents).

9
32
3
33
3
34
9
35
6
36
2
37

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Oxbryta
voxelotor
 Global Blood Theraps 32 27 $250M 2032-12-28

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11944612 Oxbryta method of use 58 2036-12-02
11944612 Oxbryta method of use 58 2036-12-02
11944612 Oxbryta method of use 58 2036-12-02
9248199 Oxbryta method of use 53 2034-01-29
9248199 Oxbryta method of use 53 2034-01-29
11452720 Oxbryta method of use 53 2035-02-06
11452720 Oxbryta method of use 53 2035-02-06
11452720 Oxbryta method of use 53 2035-02-06
11020382 Oxbryta method of use 53 2036-12-02
11020382 Oxbryta method of use 53 2036-12-02

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9447071 Oxbryta composition of matter 0 2035-02-06
9447071 Oxbryta composition of matter 0 2035-02-06
9447071 Oxbryta composition of matter 0 2035-02-06
9018210 Oxbryta composition of matter 0 2033-11-25
9018210 Oxbryta composition of matter 0 2033-11-25
9018210 Oxbryta composition of matter 0 2033-11-25
10034879 Oxbryta composition of matter 0 2032-12-28
10806733 Oxbryta composition of matter 0 2032-12-28
10034879 Oxbryta composition of matter 0 2032-12-28
10806733 Oxbryta composition of matter 0 2032-12-28

Related